Table 1.
Title | Category | Biological level | AOP wiki ID | NPs type | Organism | Reference | Percentage in the literature (%)* |
---|---|---|---|---|---|---|---|
Increase, ROS | Key event | Molecular | KE 1364 | PS | D. magna | [55] | 19.4% |
Danio rerio | [48] | ||||||
Monogonont Rotifer (Brachionus koreanus) | [26] | ||||||
Oyster gametes (Crassostrea gigas) | [75] | ||||||
Human | [71,104] | ||||||
Caenorhabditis elegans | [95] | ||||||
Oxidative stress | Key event | Molecular | KE 1392, KE 1088 | PS, PC | D. magna | [55] | 45.2% |
Fathead minnow (Pimephales promelas) | [39] | ||||||
Danio rerio | [48] | ||||||
[101] | |||||||
[15] | |||||||
Daphnia pulex | [93] | ||||||
Caenorhabditis elegans | [13] | ||||||
Oyster gametes (Crassostrea gigas) | [75] | ||||||
Monogonont Rotifer (Brachionus koreanus) | [26] | ||||||
Mussel (Mytilus galloprovincialis) | [64] | ||||||
[54] | |||||||
Human | [85] | ||||||
[14] | |||||||
[60] | |||||||
Activation of oxidative stress pathway | Key event | Molecular | KE 1238, KE 1279 | PS | D. magna | [55] | 9.7% |
Mussel (Mytilus galloprovincialis) | [54] | ||||||
Monogonont Rotifer (Brachionus koreanus) | [26] | ||||||
Lipid peroxidation | Key event | Molecular | KE: 1151 | PS | D. magna | [55] | 9.7% |
Mussel (Mytilus galloprovincialis) | [64] | ||||||
Danio rerio | [15] | ||||||
DNA damage | Key event | Cellular | KE 1669 | PS | Mussel (Mytilus galloprovincialis) | [64] | 6.5% |
Human | [60] | ||||||
Lysosome disruption | Key event | Cellular | KE 898 | PS | Mussel (Mytilus galloprovincialis) | [54] | 9.7% |
Mouse | [70] | ||||||
Human | [74] | ||||||
Mitochondrial dysfunction | Key event | Cellular | KE 1483 | PS | D. magna | [55] | 13.0% |
Mussel (Mytilus galloprovincialis) | [54] | ||||||
Mouse | [70] | ||||||
Human | |||||||
Human | [71,104] | ||||||
Acetylcholinesterase (AchE) inhibition | Key event | Cellular | KE 12 | PS | Danio rerio | [48] | 9.7% |
Caenorhabditis elegans | [13] | ||||||
Mussel (Mytilus galloprovincialis) | [64] | ||||||
Phase I metabolism enzymes activation | Key event | Molecular | KE 1386, KE 850 | PS | Daphnia pulex | [86] | 6.5% |
Mussel (Mytilus galloprovincialis) | [64] | ||||||
Pro-inflammatory cytokines activation | Key event | Cellular | KE 87, KE 1493 | PS | Danio rerio | [10] | 19.4% |
Mussel (Mytilus galloprovincialis) | [64] | ||||||
Human | [14] | ||||||
[83] | |||||||
[88] | |||||||
[90] | |||||||
Apoptosis | Key event | Cellular | KE 1262 | PS | Mussel (Mytilus galloprovincialis) | [54] | 16.1% |
Mouse | [70] | ||||||
Human | |||||||
Human | [85] | ||||||
[71,104] | |||||||
[89] | |||||||
Decrease of neuronal network function | Key event | Organ | KE 386 | PS | Danio rerio | (Brun, van Hage et al., 2019) | 6.5% |
Caenorhabditis elegans | [13] | ||||||
Inflammation; Infiltration, Inflammatory cells | Key event | Tissue/Cellular | KE 1633, KE 901 | PS, PC | Danio rerio | [10] | 13.0% |
[15] | |||||||
Rat | [90] | ||||||
Fathead minnow (Pimephales promelas) | [39] | ||||||
Bradycardia | Key event | Organ | KE 444 | PS | Danio rerio | [101] | 6.5% |
[100] | |||||||
Accumulation, Liver lipid | Key event | Organ | KE 455 | PS | Danio rerio | [15] | 3.2% |
Growth inhibition | Adverse outcome | Individual | KE 1521 KE 1467 | PS | algae (S. obliquus) | [9] | 9.7% |
Monogonont Rotifer (Brachionus koreanus) | [26] | ||||||
Caenorhabditis elegans | [13] | ||||||
Decreased body size/length | Adverse outcome | Individual | KE 315, KE 864 | PS | D. magna | [9] | 13.0% |
Danio rerio | [48] | ||||||
Caenorhabditis elegans | [13] | ||||||
[95] | |||||||
Increase, Mortality | Adverse outcome | Individual, Population | KE 350, KE 351, KE 342 |
PS | D. magna | [55] | 3.2% |
Locomotor activity, decreased | Adverse outcome | Individual | KE 1389 | PS | D. magna | [55] | 22.6% |
Danio rerio | [48] | ||||||
(Brun, van Hage et al., 2019) | |||||||
[100] | |||||||
Caenorhabditis elegans | [13] | ||||||
[95] | |||||||
Rat | [82] | ||||||
Impaired, Fertility | Adverse outcome | Individual | KE 406, KE 78 | PS | Monogonont Rotifer (Brachionus koreanus) | [26] | 3.2% |
Impaired, Development | Adverse outcome | Individual | KE 577, KE 339 | PS | Danio rerio | [101] | 13.0% |
[48] | |||||||
Caenorhabditis elegans | [13] | ||||||
D. magna | [9] |